Skip to content

Meet Our Faculty

Marwan Abouljoud, MD

Director, Henry Ford Transplant Institute Professor of Surgery (Clinician Educator) Position: Full-Time Affiliate
Office Address:
Henry Ford Hospital
2799 West Grand Boulevard
Detroit, MI 48202
Phone: (313) 916-2436
Fax: (313) 916-4353

Administrative Assistant: Jamie Carson
Administrative Email: jcarson@med.wayne.edu

SPECIALTY: Transplantation
CLINICAL INTERESTS:

Cancer Surgery, Donating An Organ, Gastrointestinal Cancer, Hepatic Hemangioma, Hepato-Pancreato-Biliary Disease (HPB), Hepatocellular Carcinoma, Hydatid Cyst, Kidney Transplant, Klatskins Tumor, Liver Adenoma, Liver and Kidney Transplantation Including Split Liver Transplantation, Liver Cancer, Liver Transplant, Liver Tumors, Organ Donation, Organ Transplantation, Pancreas Transplant, Transplant Institute, and Transplant Radiofrequency Ablation

Education

BOARD CERTIFICATION:
– American Board of Surgery – Surgery
– MI State Medical License

EDUCATION:
– MD, American University of Beirut, Lebanon
– MMM, Carnegie Mellon University – Heinz School of Management, Pittsburgh, PA

RESIDENCY:
– General Surgery, University of Michigan, Ann Arbor, MI
– General Surgery, Henry Ford Hospital, Detroit, MI

FELLOWSHIP:
– Transplant Surgery, University of Alabama, Tuscaloosa, AL
– Transplant Surgery, Baylor University Medical Center, Dallas, TX

Publications

The authors’ reply.
Nagai S, Abouljoud MS, Moonka D, Yoshida A.
Transplantation. 2014 Mar 27;97(6):e33-4. doi: 10.1097/TP.0000000000000035. No abstract available.

Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation.
Nagai S, Abouljoud MS, Kazimi M, Brown KA, Moonka D, Yoshida A. Transplantation. 2014 Mar 27;97(6):694-701. doi: 10.1097/01.TP. 0000437426.15890.1d.

Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Nagai S, Abouljoud MS, Kazimi M, Brown KA, Moonka D, Yoshida A.

Mental health affects the quality of life and recovery after liver transplantation. Miller LR, Paulson D, Eshelman A, Bugenski M, Brown KA, Moonka D, Abouljoud M.

Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
McGonigal KH, Bajjoka IE, Abouljoud MS.
Pharmacotherapy. 2013 Sep;33(9):e170-6. doi: 10.1002/phar.1306. Epub 2013 Jun 6

Teaching

Medical students in weekly didactic rounds.